Sofwave Receives FDA Clearance for Treating Upper Arm Skin Laxity
The FDA clearance of Sofwave to treat upper arm skin laxity comes as the American Society of Plastic Surgeons reports brachioplasty procedures grew 25% between 2019-2022.
The FDA clearance of Sofwave to treat upper arm skin laxity comes as the American Society of Plastic Surgeons reports brachioplasty procedures grew 25% between 2019-2022.
The collagen-based dermal regeneration template is designed for improved patient outcomes in the treatment of full-thickness wounds.